Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Clement

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Immunology|July 1, 1990
Sequential serological responses to Aspergillus fumigatus in patients with cystic fibrosis. Use of antigen 'stretching' to delineate IgG and IgE activityJ H Edwards, M Alfaham, R Fifield, et al.
Case Reports in Oncology|April 30, 2013
The use of high dosages of transdermal buprenorphine for pain management in palliative cancer patients: a case studyPaul M J Clement, Benoit Beuselinck, Karen Van Beek, et al.
The Journal of Infectious Diseases|October 1, 1990
Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infectionJ S Haas, G Bolan, S A Larsen, et al.
International Journal of Cancer|July 13, 2002
The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitroPaul M J Clement, Hartmut M Hanauske-Abel, Edith C Wolff, et al.
B-ENT|May 14, 2011
Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancerD Debaere, V Vander Poorten, S Nuyts, et al.
Case Reports in Oncology|May 18, 2019
Clinically Relevant Response to Cisplatin-5-Fluorouracyl in Intestinal-Type Sinonasal Adenocarcinoma with Loss of Vision: A Case ReportJonas Claus, Mark Jorissen, Vincent Vander Poorten, et al.
Gynecologic Oncology|July 21, 2004
Eukaryotic initiation factor 5A-1 (eIF5A-1) as a diagnostic marker for aberrant proliferation in intraepithelial neoplasia of the vulvaBernadette M Cracchiolo, Debra S Heller, Paul M J Clement, et al.
International Journal of Cancer|December 2, 1998
Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence areaP D Sturm, I O Baas, M J Clement, et al.
Human Pathology|August 26, 1998
p53 alterations in atypical alveolar hyperplasia of the human lungR J Slebos, I O Baas, M J Clement, et al.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2008
Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinomaSandra Nuyts, Piet Dirix, Paul M J Clement, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Immunology|July 1, 1990
Sequential serological responses to Aspergillus fumigatus in patients with cystic fibrosis. Use of antigen 'stretching' to delineate IgG and IgE activityJ H Edwards, M Alfaham, R Fifield, et al.
Case Reports in Oncology|April 30, 2013
The use of high dosages of transdermal buprenorphine for pain management in palliative cancer patients: a case studyPaul M J Clement, Benoit Beuselinck, Karen Van Beek, et al.
The Journal of Infectious Diseases|October 1, 1990
Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infectionJ S Haas, G Bolan, S A Larsen, et al.
International Journal of Cancer|July 13, 2002
The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitroPaul M J Clement, Hartmut M Hanauske-Abel, Edith C Wolff, et al.
B-ENT|May 14, 2011
Cyclophosphamide, doxorubicin, and cisplatin in advanced salivary gland cancerD Debaere, V Vander Poorten, S Nuyts, et al.
Case Reports in Oncology|May 18, 2019
Clinically Relevant Response to Cisplatin-5-Fluorouracyl in Intestinal-Type Sinonasal Adenocarcinoma with Loss of Vision: A Case ReportJonas Claus, Mark Jorissen, Vincent Vander Poorten, et al.
Gynecologic Oncology|July 21, 2004
Eukaryotic initiation factor 5A-1 (eIF5A-1) as a diagnostic marker for aberrant proliferation in intraepithelial neoplasia of the vulvaBernadette M Cracchiolo, Debra S Heller, Paul M J Clement, et al.
International Journal of Cancer|December 2, 1998
Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence areaP D Sturm, I O Baas, M J Clement, et al.
Human Pathology|August 26, 1998
p53 alterations in atypical alveolar hyperplasia of the human lungR J Slebos, I O Baas, M J Clement, et al.
International Journal of Radiation Oncology, Biology, Physics|August 19, 2008
Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinomaSandra Nuyts, Piet Dirix, Paul M J Clement, et al.
Pageof 4